Number of the records: 1  

XII. Výročný medzinárodný kongres Medzinárodnej spoločnosti pre farmakoekonomiku a výskum výsledkov, 19.-23. V. 2007

  1. TitleXII. Výročný medzinárodný kongres Medzinárodnej spoločnosti pre farmakoekonomiku a výskum výsledkov, 19.-23. V. 2007
    Document partČasť 2.. Infekčné ochorenia. Gastroenterológia. Neurológia. Reumatológia. Onkológia. Psychiatria
    Author infoJán Bielik
    Author Bielik Ján
    Corporation Medzinárodná spoločnosť pre farmakoekonomiku a výskum výsledkov. Medzinárodný kongres 12., 2007, Washington, USA
    NoteVoľný preklad z kongresových materiálov
    Sign.C 3079
    Source Farmakoekonomika a lieková politika : oficiálny časopis Slovenskej spoločnosti pre farmakoekonomiku. - ISSN 1336-7021. - Nové Mesto nad Váhom : TISING , 2007 . - Roč. 3, č. 4 (2007), s. 32-34 a 36-44 a 46-50 a 52 a 54-58
    Contains alsoThe clinical and economic burden of complicated skin structure infections (cSSSI) due to staphylococcus aureus: findings from a national database / J. P. Marton a kol. -- Cost-effectiveness of linezolid in gram-positive infections: consistency of economic advantage from multiple healthcare systems / S. Duttagupta a kol. -- treatment failure among community acquired pneumonia (CAP) patients treated with levofloxacin or macrolides in an oupatient settings / Xin Ye, M. S. a kol. -- Impact of S. aureus infections on expenditures and lenght-of-stay in U.S. hospitals / Gary Noskin a kol. -- Pharmacoeconomic evaluation of herd immunity conferred by seven-valent pneumococcal conjugate vaccine (Prevnar®) in Canada based on Calgary Region epidemiological data / Roman Cascciano -- Cost-effectiveness of pneumococcal vaccination for infants with 7-valent pneumococcal conjugate vaccination in Hong Kong / Lee K.K.C. a kol. -- Inclusion of pentavalent rotavirus vaccine in the New Zealand childhood immunisation schedule / Richard Milne a kol. -- Reduced mental and physical functioning among GERD patients with frequent atypical GERD symptoms / Bonnie B. Dean a kol. -- Relationship between gastroesophageal reflux disease symptoms and costs: a database study in a US cohort / Peter Wahlqvist a kol. -- Comorbidities during the year following diagnosis for persons with and without GERD using the agency for healthcare research and quality (AHRQ) 261 specific categories / Mari-Ann Wallander -- Gastroesophageal reflux disease and health-related quality of life in the general population of Shanghai, China / Mari-Ann Wallander -- Symptoms of gastroesophageal reflux disease, concomitant diseases, health-related quality of life and work productivity: a database study in a US cohort / Peter Wahlqvist a kol. -- Biological agents for the management of Crohn's disease in adults: a systematic review, meta-analysis and multiple treatment comparison / Dyfrig Hughes a kol. -- Lowwer disease activity and clinical remission are associated with reduced hospitalization risk in Crohn's disease / EQ Wu a kol. -- Retrospective comparison of treatment outcomes among hepatitis C patients treated with pegylated interferon 2A or 2B plus ribavirin at two VA medical centers / Dinges B. a kol. -- The budgetary impact of the utilization of natalizumab for the treatment of relapsing multiple sclerosis / Ciao E. a kol. -- The cost-effectiveness of natalizumab in patients with relapsing multiple sclerosis / Meyer K. a kol. -- the impact of chronic insomnia on productivity in the US, France and Japan / Martin M. a kol. -- Cost of pain therapy for osteoarthritis in a privately insured population in the United States / A. White a kol. -- Cost-effectiveness of lumiracoxib compared to celecoxib for the treatment of oasteoarthritis in Canada / Sambrook J. S. a kol. -- A comparison of healthcare costs in patients with psoriatic arthritis (PsA) who received etanercept, etanercept + methotrexate, infliximab or infliximab + methotrexate / O. Dabbous a kol. -- A comparison of switchinh patterns among anti-tumor necrosis factors (anti-TNFs) in the treatment of rheumatoid arthritis / B. Tang a kol. -- Impact of patients' out-of-pocket cost on adherence and persistence with biologic therapies for rheumatoid arthritis / Michelle Gleeson a kol. -- A comparison of therapeutic persistence among anti-tumor necrosis factors (anti-TNFs) in the treatment of rheumatoid arthritis / B. Tang a kol. -- A five-year longitudinal analysis comparing dose changes for patients with rheumatoid arthritis taking infliximab in medicare and in commercially insured populations / K. V. Nair a kol. -- Economic evaluation of biologic response modifier specialty pharmacy prior authorization program / Shawn X. Sun a kol. -- Pharmacoeconomic analysis of sorafenib and sunitinib for first-line treatment of advanced renal cell carcinoma (ARCC) at a comprehensive cancer center / Wendy D. Smith a kol. -- Health-related quality of life in patients with metastatic renal cell carcinoma treated with Axitinib (AG-013736) / Peter C. Trask a kol. -- Cost analysis of erytropoietic-stimulating therapy dosing in oncology inpatients / Aaron D. Killian a kol. -- Drug utilization, cost consideration and tranfusion patterns for erythropoiesis-stimulating agents in a managed care oncology population / Antoine Gosselin a kol. -- Medical cost consideration of fixed dosing regimens of erythropoietic agents in patients with chemotherapy-induced anemia / Patrick Lefebvre a kol. -- Analysis of dose, cost and use patterns of erythropoiesis stimulating agents in cancer patients / Daniel G. W. a kol. -- Real-world epoetin alfa (EPO) and darbepoetin alfa (DARB) dosing and cost considerations in elderly hospital inpatients: results from a large observational study / Mei S. Duh a kol. -- Correlation between time to progression and overall survival in patients with metastatic breast cancer /Sherrill B. a kol. -- Primary prophylaxis of ferile neutropenia with pegfilgrastim is cost-effective compared with secondara prophylaxis for women with early-stage breast cancer receiving chemotherapy / Ramsey S. D. a kol. -- Outpatient use of hematopoietic colony stimulating factor (CSF) among elderly cancer patients receiving chemotherapy / Ya-Chen Tina Shih a kol. -- First-line treatment and lifetime medical-care costs among elderly stage IIIB/IV non-small-cell lung cancer (NSCLC) patients treated with commonly used doublet therapies / Kathy Lang a kol. -- Analysis for price and utilization on breast cancer medications in US medicaid programs / Yan Chen a kol. -- An analysis of cost associated with administration of trastuzumab-based combination IV therapies in metastatic breast cancer patients in a US population -- Burden of illness analysis of metastatic melanoma in the United States / Lang K. a kol. -- New system of costly drug reimbursement in France: assessment in a teaching hospital oncology department / Baylatry M. T. a kol. -- Risperidone long acting injection (RLAI) in the treatment of early versus late diagnosis patients with schizophrenia: interim results from observational studies conducted in Spain, Australia and Belgium / J. M. Olivares a kol. -- 12-month treatment discontinuation rates in patients with schizophrenia treated with risperidone long acting injection (RLAI): interim results from observational studies conducted in Spain, Australia and Belgium / J. M. Olivares a kol. -- 36-month cost-utility analysis of antipsychotic treatments in patients with schizophrenia in the Paneuropean SOHO (schizophrenia outpatient health outcomes) study / Windmeijer F. a kol. -- Switching of antipsychotics among stable and unstable schizophrenia patients / Baojin Zhu, Eli Lilly a kol. -- Assessing perzistence on antipsychotics in the treatment of schizophrenia: using medicaid data to understand the challenges / Baojin Zhu, Eli Lilly a kol. -- Medication use patterns and costs associated with atypical antipsychotics in the treatment of bipolar disorder / Baojin Zhu, Eli Lilly a kol. -- Net benefit analysis of depakote ER in the treatment of bipolar disorder / Shiraz Gupta a kol.
    Extended TitleDvanásty Výročný medzinárodný kongres Medzinárodnej spoločnosti pre farmakoekonomiku a výskum výsledkov, 19.-23. V. 2007
    LanguageSlovak
    CountrySlovak Republic
    Document kindRozpis článkov z periodík
    DatabaseARTICLES
    article

    article

Number of the records: 1  

  This site uses cookies to make them easier to browse. Learn more about how we use cookies.